Scholar Rock Holding Corporation SRRK
Super Investor & Insider
1
Fondi che lo detengono
#1234
Rank consenso
1.4%
% dei portafogli
$2.6M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.02% | Add 138.72% | 51,951 | $2.6M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Scholar Rock Holding Corporation is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases where protein growth factor signaling plays a central role. It employs a proprietary platform targeting the transforming growth factor beta (TGFβ) super…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees128
TickerSRRK
Statistics
Market Cap$5.59B
Revenue (TTM)$0
Net Income-$377.9M
Net Margin—
EPS$-3.29
P/E-13.42
P/S—
P/B19.29
EV/EBITDA-12.28
ROE-138.9%
Dividend Yield—
Price$46.96
Data: Twelve Data · Revenue = mcap / P/S